| Comparative effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) vaccines in preventing COVID-19 hospitalizations among adults without immunocompromising … WH Self MMWR. Morbidity and mortality weekly report 70, 2021 | 462 | 2021 |
| Sustained effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 associated hospitalizations among adults—United States, March–July 2021 MW Tenforde MMWR. Morbidity and mortality weekly report 70, 2021 | 249 | 2021 |
| Early introductions and transmission of SARS-CoV-2 variant B. 1.1. 7 in the United States T Alpert, AF Brito, E Lasek-Nesselquist, J Rothman, AL Valesano, ... Cell 184 (10), 2595-2604. e13, 2021 | 134 | 2021 |
| A speed–fidelity trade-off determines the mutation rate and virulence of an RNA virus WJ Fitzsimmons, RJ Woods, JT McCrone, A Woodman, JJ Arnold, ... PLoS biology 16 (6), e2006459, 2018 | 108 | 2018 |
| Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts AL Valesano, KE Rumfelt, DE Dimcheff, CN Blair, WJ Fitzsimmons, ... PLoS pathogens 17 (4), e1009499, 2021 | 101 | 2021 |
| The mutational robustness of influenza A virus E Visher, SE Whitefield, JT McCrone, W Fitzsimmons, AS Lauring PLoS pathogens 12 (8), e1005856, 2016 | 101 | 2016 |
| Effectiveness of a third dose of Pfizer-BioNTech and Moderna vaccines in preventing COVID-19 hospitalization among immunocompetent and immunocompromised adults—United States … MW Tenforde MMWR. Morbidity and mortality weekly report 71, 2022 | 90 | 2022 |
| Wastewater-based detection of two influenza outbreaks MK Wolfe, D Duong, KM Bakker, M Ammerman, L Mortenson, B Hughes, ... Environmental Science & Technology Letters 9 (8), 687-692, 2022 | 82 | 2022 |
| Effectiveness of monovalent mRNA vaccines against COVID-19–associated hospitalization among immunocompetent adults during BA. 1/BA. 2 and BA. 4/BA. 5 predominant periods of … D Surie MMWR. Morbidity and mortality weekly report 71, 2022 | 55 | 2022 |
| Influenza B viruses exhibit lower within-host diversity than influenza A viruses in human hosts AL Valesano, WJ Fitzsimmons, JT McCrone, JG Petrie, AS Monto, ... Journal of Virology 94 (5), 10.1128/jvi. 01710-19, 2020 | 49 | 2020 |
| Severe acute respiratory syndrome coronavirus 2 total and subgenomic RNA viral load in hospitalized patients DE Dimcheff, AL Valesano, KE Rumfelt, WJ Fitzsimmons, C Blair, ... The Journal of infectious diseases 224 (8), 1287-1293, 2021 | 44 | 2021 |
| Validation of N95 filtering facepiece respirator decontamination methods available at a large university hospital KR Wigginton, PJ Arts, HL Clack, WJ Fitzsimmons, M Gamba, ... Open Forum Infectious Diseases 8 (2), ofaa610, 2021 | 39 | 2021 |
| Antibodies against egg-and cell-grown influenza A (H3N2) viruses in adults hospitalized during the 2017–2018 influenza season MZ Levine, ET Martin, JG Petrie, AS Lauring, C Holiday, S Jefferson, ... The Journal of Infectious Diseases 219 (12), 1904-1912, 2019 | 39 | 2019 |
| Humidity and deposition solution play a critical role in virus inactivation by heat treatment of N95 respirators N Rockey, PJ Arts, L Li, KR Harrison, K Langenfeld, WJ Fitzsimmons, ... Msphere 5 (5), 10.1128/msphere. 00588-20, 2020 | 29 | 2020 |
| SARS-CoV-2 genomic surveillance reveals little spread from a large university campus to the surrounding community AL Valesano, WJ Fitzsimmons, CN Blair, RJ Woods, J Gilbert, D Rudnik, ... Open Forum Infectious Diseases 8 (11), ofab518, 2021 | 22 | 2021 |
| Sudden onset of myelitis after COVID-19 vaccination: an under-recognized severe rare adverse event W Fitzsimmons, CS Nance Available at SSRN 3841558, 2021 | 21 | 2021 |
| The early evolution of oral poliovirus vaccine is shaped by strong positive selection and tight transmission bottlenecks AL Valesano, M Taniuchi, WJ Fitzsimmons, MO Islam, T Ahmed, K Zaman, ... Cell host & microbe 29 (1), 32-43. e4, 2021 | 20 | 2021 |
| Pre-existing heterosubtypic immunity provides a barrier to airborne transmission of influenza viruses V Le Sage, JE Jones, KA Kormuth, WJ Fitzsimmons, E Nturibi, ... PLoS Pathogens 17 (2), e1009273, 2021 | 19 | 2021 |
| Epistatic interactions within the influenza A virus polymerase complex mediate mutagen resistance and replication fidelity MD Pauly, DM Lyons, WJ Fitzsimmons, AS Lauring MSphere 2 (4), 10.1128/msphere. 00323-17, 2017 | 13 | 2017 |
| Humidity and deposition solution play a critical role in virus inactivation by heat treatment of N95 respirators. mSphere 5: e00588-20 N Rockey, PJ Arts, L Li, KR Harrison, K Langenfeld, WJ Fitzsimmons, ... | 8* | 2020 |
